Navigation Links
Raloxifene Better Than Tamoxifen For Breast Cancer

The osteoporosis drug Evista is better than Tamoxifen in preventing breast cancer in high risk post-menopausal women, new research// has suggested. Researchers said that both drugs reduce the risk of cancer by 50 percent. But the results of a 19,000-woman trial show that Eli Lilly and Co's Evista, known generically as raloxifene has fewer side effects. This fact could prompt clinicians to replace Tamoxifen with Evista in the future.

Raloxifene was found to cause less of blood clots, cataracts and uterine cancer than tamoxifen in the trial. "It is clear that raloxifene is the winner of this trial," said lead researcher Dr. Norman Wolmark, a researcher at the University of Pittsburgh Medical Center. Tamoxifen is sold as a generic drug and is widely used to prevent breast cancer, but Lilly said it would seek U.S. Food and Drug Administration approval to market Evista for this purpose. "Tamoxifen will remain the drug of choice for reducing breast cancer risk in pre-menopausal women," Vogel said. However, Raloxifene was found to cause more pre-cancerous lesions, which has puzzled doctors. "For now it will be very important for women with an increased risk of breast cancer to make an informed decision with the advice of their physician," the group said. "It is also important to note that while both drugs can prevent many breast cancers, neither has been shown to reduce the risk of death due to the disease." Of the 9,745 women in the raloxifene group, 167 developed invasive breast cancer, compared to 163 of 9,726 women in the tamoxifen group.
'"/>




Page: 1

Related medicine news :

1. Raloxifene Reduces The Risk Of Breast Cancer
2. Better prostate cancer detection
3. Better Treatment for obesity
4. For a Better Memory
5. Baby Talk Better Than Adult Speech
6. Drug Combo Works Better for children with ADHD, Tics
7. Better skin with lasers
8. Better diabetes treatment promises Vanadium
9. Better Prostate Cancer Test
10. Better Drug for Heart Transplant
11. Better Diet Even Late in Life May Prolong It
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/27/2016)... ... May 27, 2016 , ... Southland Log Homes , designer and manufacturer ... barn kits, which can be found on its website at SouthlandLogHomes.com. , The designs ... and they highlight the craftsmanship of timber post and beam construction. The result ...
(Date:5/27/2016)... (PRWEB) , ... May 27, 2016 , ... W.S. ... products, announced today that it has been recognized as one of the best small ... Badger was named as one of nine small businesses providing progressive benefits to new ...
(Date:5/27/2016)... ... 27, 2016 , ... With over 60 percent of acute stroke survivors being ... product to aid in the rehabilitation process has steadily increased. Ekso Bionics had been ... hemiplegia due to stroke. , Ekso Bionics has now received clearance from the U.S. ...
(Date:5/27/2016)... ... May 27, 2016 , ... An educational campaign ... inspiring human-interest stories, courtesy of awareness-driven celebrities and thought leaders. It also provides ... associations and industry leaders such as Bioness. , As patients feel increasingly ...
(Date:5/27/2016)... ... 2016 , ... Beleza Medspa has initiated a new program to ... the first time that Coolsculpting is being used for for more than just cosmetic ... they meet the prescribed body-fat standard, measured by the circumference-based tape method. The ...
Breaking Medicine News(10 mins):
(Date:5/27/2016)... 2016  A new study highlights the necessity of health literacy within the technology ... American College of Radiology , a majority of oncology patients undergo imaging screenings without ... http://photos.prnewswire.com/prnh/20160527/373022 ... ... Medical Diagnostic Imaging Ampronix ...
(Date:5/27/2016)... May 27, 2016 According to ... hypertension is driving ambulatory blood pressure monitoring system market ... and their ability to respond to different pressure rates, ... can lead to various cardiovascular disorders such as heart ... These diseases are growing in prevalence each year. WHO ...
(Date:5/27/2016)... May 27, 2016 ... company focused on late-stage drug development, today announced ... of pivotal batches required for registration of ... (FDA). This follows Kitov,s announcement in ... successfully met its primary efficacy endpoint. ...
Breaking Medicine Technology: